Articles By Anuja Singh
Can Johnson & Johnson’s $350 Million AI Investment in 2025 Transform Drug Discovery, R&D,…
Global – December 31, 2025 — Johnson & Johnson significantly expanded its use of artificial intelligence (AI) across…
ByAbbVie Invested $400 Million in AI in 2025: How This Will Transform Discovery, R&D,…
Global – December 31, 2025 — AbbVie Inc. significantly expanded the integration of artificial intelligence (AI) and data-driven…
Is Eli Lilly’s $450 Million AI Investment in 2025 Set to Transform Drug Discovery,…
Global – December 31, 2025 — Eli Lilly and Company significantly expanded its artificial intelligence (AI) investments in…
Is Pfizer’s $500 Million AI Investment in 2025 Poised to Redefine Drug Discovery and…
Global – December 31, 2025 — Pfizer Inc. significantly increased investment in artificial intelligence (AI) across its discovery,…
Is Biopharma’s $8.5 Billion AI Investment in 2025 Across Discovery, R&D, and Commercialization Shaping…
Global – December 31, 2025 — Biopharmaceutical companies significantly increased investment in artificial intelligence (AI) in 2025, allocating…
Does BioMark’s 2025 Corporate Update Mark the Shift from Clinical Validation to Commercial-Scale Growth…
Executive Summary BioMark’s 2025 corporate update marks a decisive inflection point as the company completes a landmark lung…
Can Johnson & Johnson’s $350 Million AI Investment in 2025 Transform Drug Discovery, R&D,…
Global – December 31, 2025 — Johnson & Johnson significantly expanded its use of artificial intelligence (AI) across…
AbbVie Invested $400 Million in AI in 2025: How This Will Transform Discovery, R&D,…
Global – December 31, 2025 — AbbVie Inc. significantly expanded the integration of artificial intelligence (AI) and data-driven…
Is Eli Lilly’s $450 Million AI Investment in 2025 Set to Transform Drug Discovery,…
Global – December 31, 2025 — Eli Lilly and Company significantly expanded its artificial intelligence (AI) investments in…
Is Pfizer’s $500 Million AI Investment in 2025 Poised to Redefine Drug Discovery and…
Global – December 31, 2025 — Pfizer Inc. significantly increased investment in artificial intelligence (AI) across its discovery,…
Is Biopharma’s $8.5 Billion AI Investment in 2025 Across Discovery, R&D, and Commercialization Shaping…
Global – December 31, 2025 — Biopharmaceutical companies significantly increased investment in artificial intelligence (AI) in 2025, allocating…
Does BioMark’s 2025 Corporate Update Mark the Shift from Clinical Validation to Commercial-Scale Growth…
Executive Summary BioMark’s 2025 corporate update marks a decisive inflection point as the company completes a landmark lung…